Design, synthesis and evaluation of benzofuran-acetamide scaffold as potential anticonvulsant agent

1. World Health Organization Information Kit on Epilepsy - What you can do, WHO, Geneva 2015, pp. 1-42; http://www.who.int/mental_health/neurology/epilepsy/epilepsy_global_toolkit.pdf, last access date December 19, 2015.Search in Google Scholar

2. D. Schmidt and W. Loscher, Drug resistance in epilepsy, Putative neurobiologic and clinical mechanisms, Epilepsia 46 (2005) 858-877; DOI: 10.1111/j.1528-1167.2005.54904.x.10.1111/j.1528-1167.2005.54904.xSearch in Google Scholar

3. D. Battino, G. Dukes and E. Perucca, Anticonvulsant, in Meyler’s Side Effects of Drugs - An Encylcopedia of Adverse Reactions and Interactions (Eds. M. N. G. Dukes and J. K. Aronson), 14th ed., Elsevier Science Publishers, New York 2000, pp. 164-197.Search in Google Scholar

4. J. M. L. Lima, The new drugs and the strategies to manage epilepsy, Curr. Pharm. Des. 6 (2008) 873-878; DOI: 10.2174/1381612003400308.10.2174/1381612003400308Search in Google Scholar

5. A. Thiry, J. M. Dogne, C. T. Supuran and B. Masereel, Carbonic anhydrase inhibitors as anticonvulsant agents, Curr. Top. Med. Chem. 7 (2007) 855-864; DOI: 10.2174/156802607780636726.10.2174/156802607780636726Search in Google Scholar

6. M. J. Brodie, Do we need any more new antiepileptic drugs? Epilepsy Res. 45 (2001) 3-6; DOI: 10.1016/S0920-1211(01)00203-0.10.1016/S0920-1211(01)00203-0Search in Google Scholar

7. C. L. P. Deckers, P. Genton, G. J. Sills and D. Schmidt, Current limitations of antiepileptic drug therapy, a conference review, Epilepsy Res. 53 (2003) 1-17; DOI: 10.1016/S0920-1211(02)00257-7.10.1016/S0920-1211(02)00257-7Search in Google Scholar

8. B. Malawska, New anticonvulsant agents, Curr. Top. Med. Chem. 5 (2005) 69-85; DOI: 10.2174/1568026053386944.10.2174/1568026053386944Search in Google Scholar

9. D. Choi, J. P. Stables and H. Kohn, Synthesis and anticonvulsant activities of N-benzyl-2-acetamido- propionamide derivatives, J. Med. Chem. 39 (1996) 1907-1916; DOI: 10.1021/jm9508705.10.1021/jm9508705Search in Google Scholar

10. A. H. Tarikogullari, F. S. Kilic, K. Erol and V. Pabuccuoglu, Synthesis and anticonvulsant activity of some alkanamide derivatives, Arzneimittelforsch. 60 (2010) 593-598; DOI: 10.1055/s-0031-1296331.10.1055/s-0031-1296331Search in Google Scholar

11. S. N. Pandeya, P. Yogeeswari and J. P. Stables, Synthesis and anticonvulsant activity of 4-bromophenyl substituted aryl semicarbazones, Eur. J. Med. Chem. 35 (2000) 879-886; DOI: 10.1016/S0223-5234(00)01169-7.10.1016/S0223-5234(00)01169-7Search in Google Scholar

12. K. M. Basavaraja, V. P. Vaidya and C. Chandrashekhar, Synthesis of benzofuro[3,2-e]-1,4-diazepines of pharmacological interest, Eur. J. Chem. 5 (2008) 567-571; DOI: 10.1155/2008/920926.10.1155/2008/920926Search in Google Scholar

13. K. M. Dawood, H. Abdel-Gawad, E. A. Rageb, M. Ellithey and H. A. Mohamed, Synthesis, anticonvulsant, and anti-inflammatory evaluation of some new benzotriazole and benzofuran-based heterocycles, Bioorg. Med. Chem. 14 (2006) 3672-3680; DOI: 10.1016/j.bmc.2006.01.033.10.1016/j.bmc.2006.01.03316464601Search in Google Scholar

14. H. Rajak, C. K. Behera, R. S. Pawar, P. K. Singour and M. D. Kharya, A novel series of 2,5-disubstituted 1,3,4-thiadiazoles as potential anticonvulsant agent, Chin. Chem. Lett. 21 (2010) 1149-1152; DOI: 10.1016/j.cclet.2010.04.012.10.1016/j.cclet.2010.04.012Search in Google Scholar

15. I. R. Sadarangani, S. Bhatia, D. Amarante, I. Lengyel and R. A. Stephani, Synthesis, resolution and anticonvulsant activity of chiral N-1’-ethyl,N-3’-(1-phenylethyl)-(R,S)-2’H,3H,5’H-spiro-(2- benzofuran-1,4’-imidazolidine)-2’,3,5’-trione diastereomers, Bioorg. Med. Chem. Lett. 22 (2012) 2507-2509; DOI: 10.1016/j.bmcl.2012.02.005.10.1016/j.bmcl.2012.02.00522401865Search in Google Scholar

16. S. Rádl, P. Hezký, J. Urbánková, P. Váchal and I. Krejči, Synthesis and analgesic activity of some 1-benzofurans, 1-benzothiophenes and indoles, Collect. Czech. Chem. Commun. 65 (2000) 280-296.10.1135/cccc20000280Search in Google Scholar

17. C. Aswathanarayanappa, E. Bheemappa, Y. D. Bodke, V. K. Bhovi, R. Ningedowda, M. C. Shivakumar, S. K. Peethambar and S. Telkar, 5-Phenyl-1-benzofuran-2-yl derivatives, synthesis, antimicrobial, and antioxidant activity, Med. Chem. Res. 22 (2013) 78-87; DOI: 10.1007/s00044-12-0017-y.Search in Google Scholar

18. T. Kosmalski, J. Kutkowska, A. K. Gzella and A. Nowakiewicz, New heterocyclic oxime ethers of 1-(benzofuran-2-yl)ethan-1-one and their antimicrobial activity, Acta Pol. Pharm. 72 (2015) 289-295.Search in Google Scholar

19. J. Cho, C. Park, Y. Lee, S. Kim, S. Bose, M. Choi, A. S. Kumar, J. K. Jung and H. Lee, Neuroprotective and antioxidant effects of novel benzofuran-2-carboxamide derivatives, Biomol. Ther. (Seoul). 23 (2015) 275-282; DOI: 10.4062/biomolther.2015.030.10.4062/biomolther.2015.030442872125995827Search in Google Scholar

20. X. D. Yang, W. C. Wan, X. Y. Deng, Y. Li, L. J. Yang, L. Li and H. B. Zhang, Design, synthesis and cytotoxic activities of novel hybrid compounds between 2-phenylbenzofuran and imidazole, Bioorg. Med. Chem. Lett. 22 (2012) 2726-2729; DOI: 10.1016/j.bmcl.2012.02.094.10.1016/j.bmcl.2012.02.09422440627Search in Google Scholar

21. M. Choi, H. Jo, H. J. Park, A. S. Kumar, J. Lee, J. Yun, Y. Kim, S. B. Han, J. K. Jung, J. Cho, K. Lee, J. H. Kwak and H. Lee, Design, synthesis, and biological evaluation of benzofuran- and 2,3-dihydrobenzofuran-2-carboxylic acid N-(substituted)phenylamide derivatives as anticancer agents and inhibitors of NF-κB, Bioorg. Med. Chem. Lett. 25 (2015) 2545-2549; DOI: 10.1016/j.bmcl.2015.04.050.10.1016/j.bmcl.2015.04.05025953156Search in Google Scholar

22. H. Kwiecień, A. Goszczyńska and P. Rokosz, Benzofuran small molecules as potential inhibitors of human protein kinases, A Review, Curr. Pharm. Des. 22 (2015); DOI: 10.2174/1381612822-666151209152457.Search in Google Scholar

23. B. Waltenberger, K. Wiechmann, J. Bauer, P. Markt, S. M. Noha, G. Wolber, J. M. Rollinger, O. Werz, D. Schuster and H. Stuppner, Pharmacophore modeling and virtual screening for novel acidic inhibitors of microsomal prostaglandin E2 synthase-1 (mPGES-1), J. Med. Chem. 54 (2011) 3163-3174; DOI: 10.1021/jm101309g.10.1021/jm101309g308831121466167Search in Google Scholar

24. Z. Wang, S. Zhang, H. Jin, W. Wang, J. Huo, L. Zhou, Y. Wang, F. Feng and L. Zhang, Angiotensin- I-converting enzyme inhibitory peptides, Chemical feature based pharmacophore generation, Eur. J. Med. Chem. 46 (2011) 3428-3433; DOI: 10.1016/j.ejmech.2011.05.007.10.1016/j.ejmech.2011.05.00721621881Search in Google Scholar

25. S. K. Bansal, B. N. Sinha and R. L. Khosa, Docking-based virtual screening of Schiff’s bases of GABA: a prospective to novel GABA-AT inhibitors, Med. Chem. Res. 21 (2012) 3063-3072; DOI: 10.1007/s00044-011-9843-6.10.1007/s00044-011-9843-6Search in Google Scholar

26. R. Sinha, S. U. V. Singh, R. L. Khosa, J. P. Stables and J. Jain, Nicotinic acid hydrazones: a novel anticonvulsant pharmacophore, Med. Chem. Res. 20 (2011) 1499-1504; DOI: 10.1007/s00044-010-9396-0.10.1007/s00044-010-9396-0Search in Google Scholar

27. W. Loscher, C. P. Fassbender and B. Nolting, The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models, Epilepsy Res. 8 (1991) 79-94.10.1016/0920-1211(91)90075-QSearch in Google Scholar

28. H. G. Vogel. Drug Discovery and Evaluation. Pharmacological Assays, 2nd ed., Springer, Berlin 2002. 398-399, 422-427.Search in Google Scholar

29. P. Yogeeswari, D. Sriram, R. Thirumurugan, J. V. Raghavendran, K. Sudhan, R. K. Pavana and J. Stables, Discovery of N-(2,6-dimethylphenyl)-substituted semicarbazones as anticonvulsants: Hybrid pharmacophore-based design, J. Med. Chem. 48 (2005) 6202-6211; DOI: 10.1021/jm050283b. 10.1021/jm050283b16190747Search in Google Scholar

30. A. K. Shakya, G. K. Patnaik and P. Mishra, Synthesis and biological activity of 2-substituted ethanamido-5-alkyl-1,3,4-thiadiazoles: Part-III, Acta Pharm. Turc. 42 (2000) 56-63.Search in Google Scholar

31. R. B. Brooks, R. E. Bruccoleri, B. D. Olafson, D. J. States, S. Swaminathan and M. Karplus, CHARMM-a program for macromolecular energy, minimization, and dynamics calculations, J. Comp. Chem. 4 (1983) 187-217; DOI: 10.1002/jcc.540040211.10.1002/jcc.540040211Search in Google Scholar

32. R. D. K. Gehlhaar, D. Bouzida and P. A. Rejto, Fully Automated and Rapid Flexible Docking of Inhibitors Covalently Bound to Serine Proteases, in: Evolutionary Programming VII, Proceedings of the 7th International Conference EP98, San Diego, March 25-27, 1998, Springer, London 1998, pp. 449-461; DOI: 10.1007/BFb0040797.10.1007/BFb0040797Search in Google Scholar

33. J. M. Yang and C. C. Chen, Gemdock, A generic evolutionary method for molecular docking, Proteins 55 (2004) 288-304; DOI: 10.1002/prot.20035.10.1002/prot.2003515048822Search in Google Scholar

34. V. M. Balaramnavar, R. Srivastava, N. Rahuja, S. Gupta, A. K. Rawat, S. Varshney, H. Chandasana, Y. S. Chhonker, P. K. Doharey, S. Kumar, S. Gautam, S. P. Srivastava, R. S. Bhatta, J. K. Saxena, A. N. Gaikwad, A. K. Srivastava and A. K. Saxena, Identification of novel PTP1B inhibitors by pharmacophore based virtual screening, scaffold hopping and docking, Eur. J. Med. Chem. 87 (2014) 578-594; DOI: 10.1016/j. ejmech.2014.09.097.Search in Google Scholar